— Know what they know.
Not Investment Advice
Also trades as: VIRP.PA (PAR) · $vol 2M

VRBCF OTC

Virbac S.A.
1W: +0.0% 1M: +0.0% 3M: -5.7% YTD: +10.8% 1Y: +10.8% 3Y: -3.4% 5Y: +14.1%
$383.25
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 37 · $3.2B mcap · 4M float · 0.0000% daily turnover · Short 73% of daily vol

📊 Key Metrics

TTM
$3B
Revenue
+14.6% YoY
$288M
Net Income
+10.7% YoY
$214M
Free Cash Flow
+25.8% YoY
36.5%
Gross Margin
17.4%
Op. Margin
11.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE26.1%
ROA14.9%
ROIC25.2%

Valuation

P/E16.6
P/B2.1
EV/EBITDA0.0

Leverage

Debt/Equity0.30
Current Ratio1.77
Interest Cov.20.5x

Quality Scores

Piotroski F7/9
Altman Z—
Beneish M-1.82

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms